Physician profile
Richard Hanna
NPI 1316925589
$3,797.06
in general payments reported to CMS, 2019-2025
37 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,102 · 2020: $1,072 · 2021: $623.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $742.45 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $523.97 | 2019-2021 | |
| Abbvie INC. | $277.12 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $225.39 | 2019-2021 | |
| Amgen INC. | $221.93 | 2019-2020 | |
| Glaxosmithkline, LLC. | $165.67 | 2019-2021 | |
| Amarin Pharma, INC. | $160.98 | 2019-2020 | |
| Pfizer INC. | $160.90 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $158.36 | 2019-2021 | |
| Allergan, INC. | $129.03 | 2019-2020 | |
| Astellas Pharma US INC | $118.25 | 2019-2021 | |
| Eisai INC. | $103.95 | 2019-2021 | |
| Lilly USA, LLC | $96.51 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.61 | 2019-2021 | |
| Bausch Health US, LLC | $67.34 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $64.98 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $49.43 | 2020-2021 | |
| Esperion Therapeutics, INC. | $46.51 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.77 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $42.29 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $39.39 | 2021 | |
| Boston Scientific Corporation | $37.97 | 2019-2020 | |
| Genentech USA, INC. | $25.29 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.29 | 2019 | |
| Hikma Pharmaceuticals USA | $16.77 | 2019 | |
| Adlon Therapeutics L.P. | $16.52 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $15.67 | 2021 | |
| Currax Pharmaceuticals LLC | $15.00 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.92 | 2021 | |
| Abbott Laboratories | $14.48 | 2021 | |
| Daiichi Sankyo INC. | $13.94 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.63 | 2019 | |
| Sebela Pharmaceuticals INC. | $13.34 | 2019 | |
| Philips North America LLC | $13.26 | 2020 | |
| Paratek Pharmaceuticals, INC. | $12.26 | 2021 | |
| Seqirus USA INC | $12.20 | 2019 | |
| Sanofi Pasteur INC. | $11.69 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Hanna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.